| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -9.3e-05 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -5e-05 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -4.6e-05 | 1 |